A two-year observational study assessing the safety of DepoFoam bupivacaine after augmentation mammaplasty

Aesthetic Surgery Journal

Volumn 32, Issue 2, 2012, Pages 186-193

  Minkowitz, Harold S ^a   Onel, Erol ^b   Patronella, Chris K ^c   Smoot, John D ^c  

^a MEMORIAL HERMANN HOSPITAL   (United States)

^b Pacira Pharmaceuticals Inc   (United States)

^c NONE

Author keywords

Anesthesia; Breast augmentation; DepoFoam bupivacaine; Infiltration; Mammaplasty

Indexed keywords

BUPIVACAINE; LIPOSOME;

ADULT; ARTICLE; BREAST AUGMENTATION; BREAST INJURY; BREAST TENDERNESS; BURNING SENSATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; FOLLOW UP; HEALING; HUMAN; LIFE EVENT; MAJOR CLINICAL STUDY; MASTALGIA; MULTICENTER STUDY; NIPPLE; OBSERVATIONAL STUDY; PARESTHESIA; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SWELLING; THORAX SURGERY;

ADULT; ANESTHETICS, LOCAL; BREAST IMPLANTATION; BREAST IMPLANTS; BUPIVACAINE; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; PATIENT SAFETY; POSTOPERATIVE COMPLICATIONS; PROSTHESIS DESIGN; QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84858184503     PISSN: 1090820X     EISSN: 1527330X     Source Type: Journal    
DOI: 10.1177/1090820X11434524     Document Type: Article

References (27)

1. American Society for Aesthetic Plastic Surgery. Cosmetic Surgery National Data Bank statistics, 2010. http://www.surgery.org/sites/default/files/ Stats2010-1.pdf. Accessed December 7, 2011.
2. Gramke HF, de Rijke JM, Van Kleef M et al. The prevalence of postoperative pain in a cross-sectional group of patients after day-case surgery in a university hospital. Clin J Pain 2007;23:543-548. (Pubitemid 46956193)
3. Wallace MS, Wallace AM, Lee J, Dobke MK. Pain after breast surgery: a survey of 282 women. Pain 1996;66:195-205. (Pubitemid 26283988)
4. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology 2004;100:1573-1581.
5. Jin F, Chung F. Multimodal analgesia for postoperative pain control. J Clin Anesth 2001;13:524-539. (Pubitemid 33028888)
6. Fayman M, Beeton A, Potgieter E, Becker PJ. Comparative analysis of bupivacaine and ropivacaine for infiltration analgesia for bilateral breast surgery. Aesthetic Plast Surg 2003;27:100-103. (Pubitemid 37243602)
7. Mahabir RC, Peterson BD, Williamson JS, et al. Locally administered ketorolac and bupivacaine for control of postoperative pain in breast augmentation patients. Plast Reconstr Surg 2004;114:1910-1916. (Pubitemid 40361907)
8. Pacik PT, Werner C, Jackson N, Lobsitz C. Pain control in augmentation mammoplasty: the use of indwelling catheters in 200 consecutive patients. Plast Reconstr Surg 2003;111:2090-2096. (Pubitemid 36532372)
9. Jirasiritham S, Tantivitayatan K, Jirasiritham S. Perianal blockage with 0.5% bupivacaine for postoperative pain relief in hemorrhoidectomy. J Med Assoc Thai 2004;87:660-664. (Pubitemid 39163105)
10. Chester JF, Stanford BJ, Gazet JC. Analgesic benefit of locally injected bupivacaine after hemorrhoidectomy. Dis Colon Rectum 1990;33:487-489. (Pubitemid 20187508)
11. Moiniche S, Mikkelsen S, Wetterslev J, Dahl JB. A qualitative systematic review of incisional local anaesthesia for postoperative pain relief after abdominal operations. Br J Anaesth 1998;81:377-383. (Pubitemid 28416617)
12. Pacik PT, Nelson CE, Werner C. Pain control in augmentation mammaplasty using indwelling catheters in 687 consecutive patients: data analysis. Aesthet Surg J 2008;28:631-641.
13. Pacik PT, Nelson CE, Werner C. Pain control in augmentation mammoplasty: safety and efficacy of indwelling catheters in 644 consecutive patients. Aesthet Surg J 2008;28:279-284. (Pubitemid 351672078)
14. Bramlett KW, Jones RK, Pink M, Pink T. A single administration of Depo Bupivacaine intraoperatively provides analgesia and reduction in use of rescue opiates compared to bupivacaine HCl in patients undergoing total knee arthroplasty [abstract 0278]. Presented at: Biennial World Congress of the International College of Surgeons; December 3-6, 2008; Vienna, Austria.
15. Golf M, Daniels SE, Onel E. A phase 3, randomized, placebo-controlled trial of Depo Foam (R) bupivacaine (extended-release bupivacaine local analgesic) in bunionectomy. Adv Ther 2011;28:776-788.
16. Gorfine SR, Onel E, Patou G, Krivokapic Z V. Bupivacaine extended-release liposome injection for prolonged postsurgical analgesia in patients undergoing hemorrhoidectomy: a multicenter, randomized, double-blind, placebo-controlled trial. Dis Colon Rectum 2011;54:1552-1559.
17. ™ (bupivacaine extended-release liposome injection), an investigational analgesic, provides postsurgical pain relief and decreased opioid use as demonstrated by integrated analysis [poster]. Presented at: Annual Meeting of the Society for Ambulatory Anesthesia; May 5-8, 2011; San Antonio, TX.
18. Holmich LR, Friis S, Fryzek JP, et al. Incidence of silicone breast implant rupture. Arch Surg 2003;138:801-806. (Pubitemid 38435314)
19. Pelosi MA III, Pelosi MA. Breast augmentation. Obstet Gynecol Clin North Am 2010;37:533-546.
20. US Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Plastic and Reconstructive Surgery Devices Branch. Guidance for industry and FDA staff: saline, silicone gel, and alternative breast implants. http://www.fda.gov/downloads/MedicalDevices/ DeviceRegulation-andGuidance/GuidanceDocuments/ucm071233.pdf. Accessed September 7, 2011.
21. International Conference on Harmonisation Working Group. ICH harmonised tripartite guideline: guideline for good clinical practice E6 (R1). Presented at: International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use; June 10, 1996; Washington, DC. http://www.ich.org/fileadmin/Public-Web-Site/ICH-Products/Guidelines/Efficacy/ E6-R1/Step4/E6-R1-Guideline.pdf. Accessed March 1, 2011.
22. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. http://www.wma.net/en/ 30publications/10policies/b3/17c.pdf. Accessed April 26, 2010.
23. US Food and Drug Administration. Breast implant questions and answers. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ ImplantsandProsthetics/BreastImplants/ucm259296.htm. Accessed May 19, 2011.
24. Jabs D, Richards BG, Richards FD. Quantitative effects of tumescent infiltration and bupivicaine injection in decreasing postoperative pain in submuscular breast augmentation. Aesthet Surg J 2008;28:528-533.
25. Kakagia D, Fotiadis S, Tripsiannis G. Levobupivacaine versus ropivacaine infiltration analgesia for mastopexy: a comparative study of 2 long-acting anesthetic drugs in infiltrative anesthesia for mastopexy. Ann Plast Surg 2005;55:258-261. (Pubitemid 41216082)
26. White PF, Ardeleanu M, Schooley GL, Burch RM. Pharmacokinetics of depobupivacaine following infiltration in patients undergoing two types of surgery and in normal volunteers [poster]. Presented at: Annual Meeting of the International Research Society; March 14, 2009; San Diego, CA.
27. ™, a multivesicular liposomal extended-release bupivacaine [abstract]. Anesth Analg 2011;112(suppl):S311.